Tissue or biological heart valve is made from animal tissue, such as porcine (pig) or bovine (cow), as it is similar to human tissue. Tissue heart valves need chemical treatment for protection and stent or frame for support. Tissue heart valves can last up to 10 to 20 years. Patients implanted with these devices do not require anticoagulation medication for a long time. Major advantages of tissue heart valves involve easy tolerance by the body and an average life expectancy of more than 15 years. However, their drawback is their durability only up to 10 to 20 years, thereby creating the need for a second replacement surgery.
MARKET DYNAMICS
The tissue heart valves market is anticipated to grow substantially due to high prevalence of heart valve diseases, which is constantly rising due to socioeconomic factors, such as lifestyle-induced dietary, physical inactivity. Moreover, increase in demand for minimally invasive procedures and technological advancements is expected to boost the growth of the market in the forecast period.
MARKET SCOPE
The "Tissue Heart Valves Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of tissue heart valves market with detailed market segmentation by type and application. The tissue heart valves market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in tissue heart valves market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The tissue heart valves market is segmented on the basis of type and application. Based on type the market is segmented as natural material and synthetic material. On the basis of application, the market is categorized as heart surgery and cardiovascular disease.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the tissue heart valves market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The tissue heart valves market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting tissue heart valves market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the tissue heart valves market in these regions.
MARKET PLAYERS
The report covers key developments in the tissue heart valves market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from tissue heart valves market are anticipated to have lucrative growth opportunities in the future with the rising demand for tissue heart valves in the global market. Below mentioned is the list of few companies engaged in the tissue heart valves market.
The report also includes the profiles of key players in tissue heart valves market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boston Scientific Corporation
- Imricor Medical Systems, Inc.
- LivaNova PLC
- Mayo Clinic US
- Medtronic plc
- MicroPort Scientific Corporation
- MRI Interventions, Inc.
- Nihon Kohden
- SCHILLER AG
- St. Jude Medical, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.